Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole Augmentation in SSRI-refractory OCD
NCT00523718Phase 2Completed
- Sponsor
- Yale University
- Start
- Sep 2006
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of riluzole in obsessive compulsive disorder (OCD), sponsored by Yale University. Started Sep 2006; status: completed.
02
Drugs
riluzole
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT00523718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523718.